Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasmJuliane Menezes, Juan C. Cigudosa, J G Talavera-Casañas et al.|Leukemia|2013Cited by 162
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phaseJuan Manuel Alonso‐Domínguez, Joaquín Martínez‐López, Luis Felipe Casado et al.|PLoS ONE|2017Cited by 10
Wilms Tumor 1 gene expression levels improve risk stratification in <scp>AML</scp> patients. Results of a multicentre study within the Spanish Group for Molecular Biology in HaematologyCarolina Martínez‐Laperche, Mi Kwon, Ana Carolina Franco-Villegas et al.|British Journal of Haematology|2017Cited by 4